Mesenchymal Stromal/Stem Cell Thawing

• Cryopreserved MSCs should be thawed from a defined cryopreservation formulation, most commonly DMSO-containing media such as 10% DMSO formulations or clinical electrolyte/albumin formulations, because these formulations have been evaluated for post-thaw MSC viability, recovery, phenotype, proliferation, and potency.

• Plasma-Lyte A with 5% human albumin, or Plasma-Lyte 148 with 2% recombinant albumin, can be used as a post-thaw dilution or formulation solution when the goal is suspension stability after thawing.

• Trypan blue is used for immediate viable-cell counting, and Annexin V/propidium iodide staining is used to distinguish viable, apoptotic, and dead MSCs after thawing.

• MSC identity after thawing can be assessed by flow cytometry for MSC surface-marker characteristics, and functional testing can include T-cell proliferation suppression or monocyte phagocytosis assays when immunomodulatory potency is the intended readout.

• A 37°C water bath is used for rapid thawing in published MSC cryopreservation workflows, and a centrifuge, biosafety cabinet, cell counter or hemocytometer, flow cytometer, and standard cell-culture incubator are used for post-thaw washing, counting, phenotype testing, apoptosis testing, and recovery culture.

• Pre-warm the 37°C water bath and prepare the literature-supported post-thaw dilution/formulation solution before removing MSCs from cryostorage, because reported MSC protocols evaluate cells immediately after thawing and at defined post-thaw time points, and delays can confound recovery and apoptosis measurements.

• Prepare viability and apoptosis assays before thawing, because studies measured MSC quality at 0 h and later post-thaw time points such as 2, 4, 6, and 24 h.

• Remove the MSC vial or bag from cryostorage and thaw rapidly in a 37°C water bath until the frozen contents are just liquefied;
• Rapid 37°C thawing is reported in MSC cryopreservation studies evaluating post-thaw viability and function.

• Dilute thawed MSCs using the same dilution strategy defined for the product or experiment;
• One MSC product study evaluated no dilution from 3 × 10⁶ cells/mL, 1:1 dilution from 6 × 10⁶ cells/mL, and 1:2 dilution from 9 × 10⁶ cells/mL with Plasma-Lyte A/5% human albumin to obtain a final 3 × 10⁶ cells/mL suspension.

• Measure post-thaw viable-cell concentration and recovery immediately after thawing using trypan blue exclusion, and assess apoptosis/death with Annexin V/PI when the protocol requires more detailed viability discrimination.

• When washed or reformulated cells are required, centrifuge and resuspend using the published product-specific formulation rather than introducing unvalidated buffers;
• Published MSC studies support Plasma-Lyte/albumin-based formulations for post-thaw suspension stability.

• For recovery-culture assessment, seed thawed MSCs into standard MSC culture conditions and assess proliferation or functional recovery after the reported recovery interval;
• One comparative study assessed proliferation after 6 days of recovery culture, and another reported restoration of IFN-γ responsiveness and immunosuppression after 24 h of post-thaw culture.

Post-thaw viability declines during short-term holding:

MSC apoptosis increases over time after thawing, and thawed MSCs showed higher apoptotic fractions beyond 4 h in one study.
Solution
Measure viability at defined post-thaw times and minimize unvalidated holding; if holding is required, use literature-supported albumin/electrolyte formulations and validate the acceptable window for the specific MSC product.

Viability appears acceptable, but immunosuppressive potency is reduced:

Freshly thawed cryopreserved MSCs can show impaired IFN-γ licensing and reduced T-cell suppression.
Solution
Include a functional potency assay and, where compatible with the intended use, evaluate a 24 h post-thaw recovery culture because immunosuppressive activity and IFN-γ responsiveness were restored after 24 h culture in the cited study.

High-density thawed products show reduced recovery after dilution:

A 1:2 dilution of MSCs cryopreserved at 9 × 10⁶ cells/mL improved viability over 6 h but showed a trend toward decreased recovery.
Solution
Report both viability and recovery after dilution, and validate the chosen dilution ratio for the starting cell concentration.